Osaka University · Faculty of Medicine / Graduate School of Medical Sciences · 助教

Research keywordshepatocellular carcinoma・liver fibrogenesis・portal hypertension・MASLD・HBs antigen secretion・CRISPR screening・immune cold tumors・hepatitis B・portal vein thrombosis

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Comparison of outcomes of second-line durvalumab plus tremelimumab versus lenvatinib following first-line atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.2026 · PloS one Vol. 21 No. 5 2026年 研究論文（学術雑誌）
• On-treatment viral factors affect subsequent hepatitis B surface antigen seroclearance in patients treated with nucleos(t)ide analogs for > 10 years.2026 · Journal of gastroenterology 2026年4月21日 研究論文（学術雑誌）
• Genome-wide CRISPR screen identifies ACSL3 as a regulator of lipotoxicity and progression of MASLD.2026 · Hepatology communications Vol. 10 No. 2 2026年2月1日 研究論文（学術雑誌）
• TEAD Inhibition as a Therapeutic Strategy Targeting Hepatocellular Carcinoma and Its Fibrotic Microenvironment2026 · CANCER SCIENCE 2026年 研究論文（学術雑誌）

• 慢性肝疾患の病態進展におけるDfna5の意義についての検討
• TEADを標的とした慢性肝疾患の治療戦略についての検討

• Official profile
• ORCID